GLP-1RA-mediated cardiovascular protection is manifested through multiple mechanisms, including oxidative stress, inflammation, endoplasmic reticulum stress, apoptosis, and vascular/cardiac remodeling.
Adverse effects and management. GLP-1 Receptor Agonists Practice Tool.However, long-term glucose control may decrease the risk of diabetic retinopathy. Ensure patients are routinely screened for retinopathy and blood glucose and blood pressure are optimized.
GLP-1 agonists have shown promising effects on menstrual cycle regularity, particularly in women with PCOS. Research indicates that these medications can help restore regular ovulation, which is often disrupted in women with PCOS due to hormonal imbalances.
Mounjaro (tirzepatide) is the first and only, once-weekly approved single-molecule GIP and GLP-1 receptor agonist that helps lower A1C for adults with type 2 diabetes.
GLP-1 agonists have a protective effect in acute lung injury and ARDS. GLP-1 promotes the production of surfactant through PKA-dependent and PKC-dependent mechanisms (149, 150).
Ozempic (semaglutide) is a GLP-1 receptor agonist licensed in the UK for type 2 diabetes mellitus. Gastrointestinal side effects, including gas, bloating, and abdominal distension, are among the most commonly reported adverse reactions.
